ProfileGDS2971 / 10.3.9.3
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 44% 35% 78% 71% 58% 76% 95% 34% 34% 7% 55% 80% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)-0.041306144
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)-0.1402435
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 20.46859978
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)0.40316471
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)0.12644858
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)0.38494976
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)1.4216895
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)-0.24687734
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)-0.18654534
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)-1.897527
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)0.10484355
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)0.82796180